Macugen Receives FDA's Broad Approval For All Wet AMD Types Dec. 21, 2004 By Aaron Lorenzo The FDA authorized the first anti-angiogenic treatment for ophthalmology, Macugen, which received approval for the treatment of neovascular (wet) age-related macular degeneration.(BioWorld Today)Read More
